Hematologic Malignancy
Acute Lymphoblastic Leukemia
CI-CAN-00000400ALLExplore in graph →
Hematologic546 active trials12 approved drugs43 evidence items
- NCIt
- C3167
- DOID
- 9952
- MeSH
- D054198
- Other
- 3 more codes
Loading cancer entity…
Loading cancer entity…
Hematologic Malignancy
CI-CAN-00000400ALLExplore in graph →
Clinical trials
2,037 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (268)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04655378 | Validation of the IgA1 Detection Method With Gradient Glycosylation by Mass Spectrometry as a Potential Marker of Renal Involvement in Pediatric Rheumatoid Purpura(FOXIGA-2020) | completed | — | 52 | Centre Hospitalier Universitaire de NīmesOTHER | 1 | Feb 8, 2023 | clinicaltrials |
| NCT03318393 | Study Comparing Bivalirudin Versus Heparin in Neonatal and Pediatric ECMO | completed | Phase 4 | 30 | University of Texas Southwestern Medical CenterOTHER |
| 1 |
| Jan 31, 2023 |
| clinicaltrials |
| NCT02593123 | Adoptive Immunotherapy in Relapsed Hematological Malignancy: Early GVHD Prophylaxis | completed | Phase 2 | 31 | Virginia Commonwealth UniversityOTHER | 1 | Jan 23, 2023 | clinicaltrials |
| NCT02807883 | Blinatumomab Maintenance Following Allogeneic Hematopoietic Cell Transplantation for Patients With Acute Lymphoblastic Leukemia | completed | Phase 2 | 23 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 20, 2023 | clinicaltrials |
| NCT05679817 | How Effective is the Dose-graded Aerobic Training in Children Survivors of Acute Lymphoblastic Leukemia? | completed | N/A | 58 | Cairo UniversityOTHER | 1 | Jan 11, 2023 | clinicaltrials |
| NCT00849147 | Bone Marrow Transplant From Partially Matched Donors and Nonmyeloablative Conditioning for Blood Cancers (BMT CTN 0603) | completed | Phase 2 | 55 | Medical College of WisconsinOTHER | 1 | Jan 4, 2023 | clinicaltrials |
| NCT04629430 | Effects of Prebiotics on Gut Microbiome in Patients Undergoing HSCT(HCTDiet) | completed | N/A | 40 | University of VirginiaOTHER | 1 | Jan 4, 2023 | clinicaltrials |
| NCT05393375 | Arthrogryposis Multiplex Congenita in Pediatric Age: Correlation Between MUScular MRI and Functional Evaluation(AMUSE) | completed | — | 97 | University Hospital, GrenobleOTHER | 1 | Jan 4, 2023 | clinicaltrials |
| NCT05656937 | Oblique Versus Transverse Orientation Approach for Internal Jugular Venous Cannulation in Pediatrics | completed | N/A | 60 | Indonesia UniversityOTHER | 1 | Dec 19, 2022 | clinicaltrials |
| NCT00864227 | Evaluating the Safety and Effectiveness of an Umbilical Cord Blood Stem Cell Transplant (BMT CTN 0604) | completed | Phase 2 | 54 | Medical College of WisconsinOTHER | 1 | Dec 14, 2022 | clinicaltrials |
| NCT05642117 | Pediatric Telephone Center Board 15(CTPC15) | completed | — | 785 | University Hospital, BrestOTHER | 1 | Dec 8, 2022 | clinicaltrials |
| NCT05563545 | Anti-CD19 CAR-Engineered NK Cells in the Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia | completed | Phase 1 | 2 | Shanghai Simnova Biotechnology Co.,Ltd.INDUSTRY | 1 | Nov 28, 2022 | clinicaltrials |
| NCT01272817 | Nonmyeloablative Allogeneic Transplant(Mini-allo) | completed | N/A | 36 | Scripps HealthOTHER | 1 | Nov 23, 2022 | clinicaltrials |
| NCT01364363 | Unrelated Donor Stem Cell Transplantation | completed | N/A | 64 | Scripps HealthOTHER | 1 | Nov 23, 2022 | clinicaltrials |
| NCT02003612 | Historical Data Analysis of Hematological Remission and Survival in Adults With R/R Acute Lymphoblastic Leukemia | completed | — | 2,373 | AmgenINDUSTRY | 8 | Nov 7, 2022 | clinicaltrials |
| NCT01586455 | Human Placental-Derived Stem Cell Transplantation(HPDSC) | completed | Phase 1 | 43 | New York Medical CollegeOTHER | 1 | Oct 25, 2022 | clinicaltrials |
| NCT01842672 | Mitoxantrone and Clofarabine for Treatment of Recurrent NHL or Acute Leukemia(MITCL) | completed | Phase 1 / Phase 2 | 41 | New York Medical CollegeOTHER | 1 | Oct 25, 2022 | clinicaltrials |
| NCT03349281 | Pevonedistat With VXLD Chemotherapy for Adolescent/Young Adults With Relapsed/Refractory ALL or Lymphoblastic NHL | completed | Phase 1 | 6 | Julio Barredo, MDOTHER | 1 | Oct 20, 2022 | clinicaltrials |
| NCT05565040 | Concealed Penis in Pediatric Age Group | completed | N/A | 150 | Egyptian Biomedical Research NetworkNETWORK | 1 | Oct 7, 2022 | clinicaltrials |
| NCT01700946 | Therapy for Pediatric Relapsed or Refractory Precursor B-Cell Acute Lymphoblastic Leukemia and Lymphoma | completed | Phase 2 | 80 | St. Jude Children's Research HospitalOTHER | 1 | Sep 28, 2022 | clinicaltrials |
| NCT04456959 | InO - A Retrospective Study of UK Patients With Leukaemia(InO) | completed | — | 28 | PfizerINDUSTRY | 1 | Sep 28, 2022 | clinicaltrials |
| NCT03581045 | Postural Control Under Different Cognitive Loads in Adult Survivors of Acute Lymphoblastic Leukemia and Age-Matched Healthy Individuals | completed | — | 92 | St. Jude Children's Research HospitalOTHER | 1 | Sep 19, 2022 | clinicaltrials |
| NCT02010931 | Retrospective Analysis of Survival in Adult MRD Positive Acute Lymphoblastic Leukemia Patients | completed | — | 310 | AmgenINDUSTRY | 8 | Sep 15, 2022 | clinicaltrials |
| NCT03455140 | A Study Evaluating the Safety and Activity of Pegylated Recombinant Human Arginase (BCT-100)(PARC) | completed | Phase 1 / Phase 2 | 49 | University of BirminghamOTHER | 3 | Sep 2, 2022 | clinicaltrials |
| NCT04248218 | Concussion Active Rehabilitation | completed | N/A | 55 | Children's National Research InstituteOTHER | 1 | Aug 30, 2022 | clinicaltrials |
| NCT00549848 | Total Therapy Study XVI for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia | completed | Phase 3 | 600 | St. Jude Children's Research HospitalOTHER | 1 | Aug 23, 2022 | clinicaltrials |
| NCT00198991 | German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (07/2003) | completed | Phase 4 | 1,883 | Goethe UniversityOTHER | 1 | Aug 18, 2022 | clinicaltrials |
| NCT00199108 | Treatment of Acute Lymphoblastic Leukemia or Aggressive Lymphoma With Relapse in Central Nervous System With Depocyt | completed | Phase 2 / Phase 3 | 20 | Goethe UniversityOTHER | 1 | Aug 18, 2022 | clinicaltrials |
| NCT00684619 | 506U78 In Relapsed Or Refractory Acute Lymphoblastic Leukemia (T-ALL) | completed | Phase 2 | 120 | Goethe UniversityOTHER | 1 | Aug 18, 2022 | clinicaltrials |
| NCT00897507 | DNA Analysis of Tumor Tissue Samples From Young Patients With Acute Lymphoblastic Leukemia | completed | — | 520 | Children's Oncology GroupNETWORK | 1 | Aug 15, 2022 | clinicaltrials |
| NCT04589910 | Measuring Thickness of the Normal Diaphragm in Children Via Ultrasound. | completed | N/A | 120 | Erasmus Medical CenterOTHER | 1 | Aug 12, 2022 | clinicaltrials |
| NCT01119066 | HLA-Compatible Related or Unrelated Donors With CD34+ Enriched, T-cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System in the Treatment of Patients With Hematologic Malignancies | completed | Phase 2 | 422 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 5, 2022 | clinicaltrials |
| NCT04638595 | Pediatric Normative Movement Analysis Data Collection | completed | — | 50 | MultiCare Health System Research InstituteOTHER | 1 | Aug 5, 2022 | clinicaltrials |
| NCT04452604 | Multicentric Registry of Patients With Acute Leukemia Infected by COVID-19(COVLA) | completed | — | 79 | French Innovative Leukemia OrganisationOTHER | 1 | Jul 27, 2022 | clinicaltrials |
| NCT01005277 | Study of Biomarkers in DNA Samples From Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia | completed | — | 2,000 | Children's Oncology GroupNETWORK | 1 | Jul 14, 2022 | clinicaltrials |
| NCT03023046 | Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma | completed | Phase 2 | 54 | University of WashingtonOTHER | 1 | Jul 13, 2022 | clinicaltrials |
| NCT05349201 | CAR T Cells Real World Evidence Study Based on the French Hospital Claims Data Source (PMSI) | completed | — | 273 | Novartis PharmaceuticalsINDUSTRY | 1 | Jul 1, 2022 | clinicaltrials |
| NCT02529813 | CD19-Specific T-cells in Treating Patients With Advanced Lymphoid Malignancies | completed | Phase 1 | 26 | M.D. Anderson Cancer CenterOTHER | 1 | Jun 30, 2022 | clinicaltrials |
| NCT02551718 | High Throughput Drug Sensitivity Assay and Genomics- Guided Treatment of Patients With Relapsed or Refractory Acute Leukemia | completed | N/A | 34 | University of WashingtonOTHER | 1 | Jun 30, 2022 | clinicaltrials |
| NCT02447718 | Vaccinating Children After Chemotherapy | completed | Phase 4 | 156 | Canadian Immunization Research NetworkNETWORK | 1 | Jun 24, 2022 | clinicaltrials |
| NCT02046694 | A Pilot Study of Allopurinol As A Modifier of 6-MP Metabolism in Pediatric ALL | completed | Early Phase 1 | 34 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Jun 21, 2022 | clinicaltrials |
| NCT02813252 | Long-Term Follow-up Study for Patients Previously Treated With JCAR015 | completed | — | 15 | Juno Therapeutics, a Subsidiary of CelgeneINDUSTRY | 1 | Jun 3, 2022 | clinicaltrials |
| NCT03627208 | Optimal Methods of Disease Detection in Children and Young Adults With Acute Lymphoblastic Leukemia in the Pediatric Oncology Branch | completed | — | 150 | National Cancer Institute (NCI)NIH | 1 | Jun 1, 2022 | clinicaltrials |
| NCT03483324 | Trial of AB-110 in Adults With Hematologic Malignancies Undergoing Cord Blood Transplantation | completed | Phase 1 | 10 | Angiocrine BioscienceINDUSTRY | 1 | May 31, 2022 | clinicaltrials |
| NCT01865617 | Laboratory Treated T Cells in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, or Acute Lymphoblastic Leukemia | completed | Phase 1 / Phase 2 | 204 | Fred Hutchinson Cancer CenterOTHER | 1 | May 25, 2022 | clinicaltrials |
| NCT03429387 | PET/CT and Bacterial/Fungal PCR in High Risk Febrile Neutropenia(PIPPIN) | completed | N/A | 147 | Peter MacCallum Cancer Centre, AustraliaOTHER | 1 | May 17, 2022 | clinicaltrials |
| NCT04330261 | Clinical Characteristics and Outcomes of Pediatric COVID-19(PERN-COVID-19) | completed | — | 10,610 | University of CalgaryOTHER | 1 | May 17, 2022 | clinicaltrials |
| NCT00061945 | Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia | completed | Phase 1 / Phase 2 | 302 | National Cancer Institute (NCI)NIH | 1 | May 3, 2022 | clinicaltrials |
| NCT00450450 | Donor Bone Marrow Transplant With or Without G-CSF in Treating Young Patients With Hematologic Cancer or Other Diseases | completed | Phase 3 | 27 | Children's Oncology GroupNETWORK | 1 | Apr 28, 2022 | clinicaltrials |
| NCT03825718 | A Study of GC007F CAR-T Cell Immunotherapy for Relapsed or Refractory B- ALL | completed | Early Phase 1 | 29 | Hebei Yanda Ludaopei HospitalOTHER | 1 | Apr 28, 2022 | clinicaltrials |
Data updated 23 days agoSource updated Feb 8, 2023source: clinicaltrials